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We appreciate Dr Weisberg’s concern that delayed en- 
hancement at the operative site may simply represent recur- 
rent tumor. We therefore provide clinical and radiographic 
follow-up data on patients in whom postoperative enhance- 
ment appeared along the line of resection (Table). Late CT 
scan observations when considered together with the clinical 
course suggest the following: (1) “benign” contrast enhance- 
ment can occur after brain tumor surgery; its appearance is 
delayed and it disappears spontaneously; and (2) when en- 
hancement at the operative site persists for longer than 3 to 4 
months, there is increasing concern that recurrent tumor is a 
contributing factor. 
Frequent postoperative CT scans were the “methods of 
procedure” by which we analyzed patterns of contrast en- 
hancement in the postoperative brain. Dr Weisberg has con- 
fused our method with our conclusion. We recommend a 
single postoperative scan, but we also recommend that this 
scan be performed on the third or fourth postoperative day. 
Postoperative enhancement in brain tumor patients is more 
than a radiological curiosity. It can mimic residual enhancing 
tumor leading to inappropriate treatment decisions and mis- 
interpretations of response to treatment 123. 
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Episodic Tourette’s 
Syndrome in a Patient 
with Citrullinemia 
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James F. Mellinger, MD,f 
and Virginia V. Michels, MD$ 
We describe the case of a 13-year-old girl with citrullinemia 
who in the course of episodic metabolic imbalances devel- 
oped symptoms of Tourette’s syndrome. Citrullinemia was 
diagnosed at ten weeks of age and she has been the subject 
of previous communications in the literature [ 11. Treatment 
consisted of protein restriction and supplemental essential 
amino acids. She did well on this regimen, although intercur- 
rent infections triggered rare 1- to 2-day episodes of ataxia, 
irritability, and lethargy associated with hyperammonemia. 
At 11 years of age she developed episodes of additional 
symptoms of repetitive tics accompanied by involuntary 
vocalizations. 
She was referred to the Mayo Clinic for an attack follow- 
ing a bout of gastroenteritis. Her parents described echolalia, 
but by the time of her evaluation she showed only lethargy, 
combativeness, and ataxia. Routine laboratory findings were 
normal. Abnormal laboratory values consisted of: ammonia, 
165 &dl (normal, less than 50); plasmaglutamine, 207 p d  
dl (normal, 34 to 67) ;  and citrulline, 203 p d d l  (normal 1.6 
to 5.5). The patient was treated with intravenous fluids, pro- 
tein restriction, supplemental arginine, and sodium benzoate, 
followed by rapid improvement. On the next day examina- 
tion findings were normal. An electroencephalogram showed 
mild generalized slowing. Computed tomographic scan 
showed only a prominent sulcus in the left parietal cortex. 
The impression was that she had an episodic form of 
Tourette’s syndrome precipitated by hyperammonemia and 
elevated concentrations of certain amino acids. It was hoped 
that the patient would return during future attacks to allow 
further assessment, including video monitoring, but the par- 
ents elected to obtain medical care closer to home. 
While we observed this child on only one occasion and are 
basing our impression of Tourette’s syndrome on history 
alone, we believe it worthwhile to note this possible associa- 
tion. Citrullinemia produced by arginosuccinate synthetase 
deficiency is a rare disorder of the urea cycle, and elevated 
serum ammonia values is the hallmark. Cases are known {2 ]  
in which citrullinemia was associated with normal ammonia 
levels; therefore, ill effects on the nervous system may not 
always be, or all be, due to the hyperammonemia. The brain 
alters ammonia primarily by forming glutamine, with gluta- 
mate-a known excitatory neurotransmitter-as an inter- 
mediate metabolite {43. It is of interest that Walser 131 cites 
cases from the Japanese literature in which patients with the 
late-onset type of citrullinemia show behavioral changes, 
with manic episodes, frank psychosis, and echolalia. 
We speculate that some transient disturbance of neuro- 
transmission was responsible for the episodic Tourette’s syn- 
drome described in this patient. 
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